Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow All Versions of this Article:
1087057107304645v1
12/6/865    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dams, G.
Right arrow Articles by Hertogs, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dams, G.
Right arrow Articles by Hertogs, K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion

Géry Dams

Tibotec BVBA, Mechelen, Belgium

Koen Van Acker

Tibotec BVBA Gen De Wittelaan L 11B 3 2800 Mechelen, Belgium E-mail: kvacker{at}tibbe.jnj.com

Emmanuel Gustin

Tibotec BVBA, Mechelen, Belgium

Inge Vereycken

Tibotec BVBA, Mechelen, Belgium

Lieve Bunkens

Tibotec BVBA, Mechelen, Belgium

Pascale Holemans

Tibotec BVBA, Mechelen, Belgium

Liesbet Smeulders

Tibotec BVBA, Mechelen, Belgium

Reginald Clayton

Tibotec BVBA, Mechelen, Belgium

Asa Ohagen

Tibotec BVBA, Mechelen, Belgium

Kurt Hertogs

Tibotec BVBA, Mechelen, Belgium

Fusion of host cell and human immunodeficiency virus type 1 (HIV-1) membranes is mediated by the 2 "heptad-repeat" regions of the viral gp41 protein. The collapse of the C-terminal heptad-repeat regions into the hydrophobic grooves of a coiled-coil formed by the corresponding homotrimeric N-terminal heptad-repeat regions generates a stable 6-helix bundle. This brings viral and cell membranes together for membrane fusion, facilitating viral entry. The authors developed an assay based on soluble peptides derived from the gp41 N-terminal heptad-repeat region (IQN36) as well as from the C-terminal region (C34). Both peptides were labeled with fluorophores, IQN36 with allophycocyanin (APC) and C34 with the lanthanide europium (Eu3+). Formation of the 6-helix bundle brings both fluorophores in close proximity needed for Förster resonance energy transfer (FRET). Compounds that interfere with binding of C34-Eu with IQN36-APC suppress the FRET signal. The assay was validated with various peptides and small molecules, and quenching issues were addressed. Evaluation of a diversified compound collection in a high-throughput screening campaign enabled identification of small molecules with different chemical scaffolds that inhibit this crucial intermediate in the HIV-1 entry process. This study's observations substantiate the expediency of time-resolved FRET-based assays to identify small-molecule inhibitors of protein-protein interactions. (Journal of Biomolecular Screening 2007:865-874)

Key Words: HIV-1 • gp41 • fusion inhibitor • screening • Förster resonance energy transfer

This version was published on September 1, 2007

Journal of Biomolecular Screening, Vol. 12, No. 6, 865-874 (2007)
DOI: 10.1177/1087057107304645
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?